Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Summary of Significant Accounting Policies - Summary of Consolidated Operating Subsidiaries (Details)

v3.25.2
Summary of Significant Accounting Policies - Summary of Consolidated Operating Subsidiaries (Details)
12 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Virax Biolabs Group Limited    
Disclosure of reclassifications or changes in presentation [line items]    
Jurisdiction Cayman Island Cayman Island
Incorporation Date Sep. 02, 2021 Sep. 02, 2021
Virax Biolabs (UK) Limited    
Disclosure of reclassifications or changes in presentation [line items]    
Jurisdiction United Kingdom United Kingdom
Incorporation Date Aug. 19, 2021 Aug. 19, 2021
Ownership 100.00% 100.00%
Virax Biolabs Limited    
Disclosure of reclassifications or changes in presentation [line items]    
Jurisdiction Hong Kong Hong Kong
Incorporation Date Apr. 14, 2020 Apr. 14, 2020
Ownership 100.00% 100.00%
Virax Immune T- Cell Medical Device Company Limited    
Disclosure of reclassifications or changes in presentation [line items]    
Jurisdiction Hong Kong Hong Kong
Incorporation Date Jan. 16, 2017 Jan. 16, 2017
Ownership 100.00% 100.00%
Virax Biolabs Pte. Limited    
Disclosure of reclassifications or changes in presentation [line items]    
Jurisdiction Singapore Singapore
Incorporation Date May 04, 2013 May 04, 2013
Ownership 95.54% 95.54%
Logico Bioproducts Corp.    
Disclosure of reclassifications or changes in presentation [line items]    
Jurisdiction BVI BVI
Incorporation Date Jan. 21, 2011 Jan. 21, 2011
Ownership 95.54% 95.54%
Shanghai Xitu Consulting Co., Limited    
Disclosure of reclassifications or changes in presentation [line items]    
Jurisdiction PRC PRC
Incorporation Date Oct. 27, 2017 Oct. 27, 2017
Ownership 95.54% 95.54%
Virax Biolabs USA Management, Inc.    
Disclosure of reclassifications or changes in presentation [line items]    
Jurisdiction USA USA
Incorporation Date Aug. 01, 2022 Aug. 01, 2022
Ownership 100.00% 100.00%
Virax Biolabs Group Holdings Ltd    
Disclosure of reclassifications or changes in presentation [line items]    
Jurisdiction United Kingdom United Kingdom
Incorporation Date Feb. 22, 2023 Feb. 22, 2023
Ownership 100.00% 100.00%
Virax Biolabs Trading B.V.    
Disclosure of reclassifications or changes in presentation [line items]    
Jurisdiction Netherlands Netherlands
Incorporation Date Aug. 04, 2023 Aug. 04, 2023
Ownership 100.00% 100.00%
Virax Biolabs UK Operating Limited    
Disclosure of reclassifications or changes in presentation [line items]    
Jurisdiction United Kingdom United Kingdom
Incorporation Date Nov. 07, 2023 Nov. 07, 2023
Ownership 100.00% 100.00%